Hemangioblastomas
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease (NCT01015300) | Dartmouth-Hitchcock Medical Center | 2009-12-01 |
Track Hemangioblastomas automatically
Every clearance here is in the API, with alerts when new ones post.